GlycoNAVI-Proteins is dataset of glycan and protein information. This is the content of GlycoNAVI.
Source | Last Updated |
---|---|
GlycoNAVI Proteins | December 11, 2024 |
PDB ID | UniProt ID | Title ▲ | Descriptor |
---|---|---|---|
1IM0 | P0A921 | OUTER MEMBRANE PHOSPHOLIPASE A FROM ESCHERICHIA COLI N156A ACTIVE SITE MUTANT PH 8.3 | |
1ILD | P0A921 | OUTER MEMBRANE PHOSPHOLIPASE A FROM ESCHERICHIA COLI N156A ACTIVE SITE MUTANT pH 4.6 | |
1ILZ | P0A921 | OUTER MEMBRANE PHOSPHOLIPASE A FROM ESCHERICHIA COLI N156A ACTIVE SITE MUTANT pH 6.1 | |
1EBV | P05979 | OVINE PGHS-1 COMPLEXED WITH SALICYL HYDROXAMIC ACID | |
5TG4 | Q8RLA6 | OXA-24/40 in Complex with Boronic Acid BA16 | |
5FTT | F1LW30 | Octameric complex of Latrophilin 3 (Lec, Olf) , Unc5D (Ig, Ig2, TSP1) and FLRT2 (LRR) | |
5FTT | Q8BLU0 | Octameric complex of Latrophilin 3 (Lec, Olf) , Unc5D (Ig, Ig2, TSP1) and FLRT2 (LRR) | |
5FTT | Q80TS3 | Octameric complex of Latrophilin 3 (Lec, Olf) , Unc5D (Ig, Ig2, TSP1) and FLRT2 (LRR) | |
2XSB | Q2CEE3 | OgOGA PUGNAc complex | |
8DE6 | P02748 | Oligomeric C9 in complex with aE11 Fab | |
8DE6 | 8DE6 | Oligomeric C9 in complex with aE11 Fab | |
1H4G | 1H4G | Oligosaccharide-binding to family 11 xylanases: both covalent intermediate and mutant-product complexes display 2,5B conformations at the active-centre | |
1H4H | 1H4H | Oligosaccharide-binding to family 11 xylanases: both covalent intermediate and mutant-product complexes display 2,5B conformations at the active-centre | |
7ZF6 | 7ZF6 | Omi-12 Fab | |
8GOU | P0DTC2 | Omicron BA.4/5 SARS-CoV-2 S in complex with TH003 Fab | |
8GOU | 8GOU | Omicron BA.4/5 SARS-CoV-2 S in complex with TH003 Fab | |
7YVE | P0DTC2 | Omicron BA.4/5 SARS-CoV-2 S in complex with TH027 Fab | |
7YVE | 7YVE | Omicron BA.4/5 SARS-CoV-2 S in complex with TH027 Fab | |
7YVO | P0DTC2 | Omicron BA.4/5 SARS-CoV-2 S in complex with TH027/132 Fab | |
7YVO | 7YVO | Omicron BA.4/5 SARS-CoV-2 S in complex with TH027/132 Fab | |
7YVG | P0DTC2 | Omicron BA.4/5 SARS-CoV-2 S in complex with TH132 Fab | |
7YVG | 7YVG | Omicron BA.4/5 SARS-CoV-2 S in complex with TH132 Fab | |
7YVI | P0DTC2 | Omicron BA.4/5 SARS-CoV-2 S in complex with TH236 Fab | |
7YVI | 7YVI | Omicron BA.4/5 SARS-CoV-2 S in complex with TH236 Fab | |
7YVK | P0DTC2 | Omicron BA.4/5 SARS-CoV-2 S in complex with TH272 Fab | |
7YVK | 7YVK | Omicron BA.4/5 SARS-CoV-2 S in complex with TH272 Fab | |
7YVP | P0DTC2 | Omicron BA.4/5 SARS-CoV-2 S in complex with TH272/281 Fab | |
7YVP | 7YVP | Omicron BA.4/5 SARS-CoV-2 S in complex with TH272/281 Fab | |
7YVN | P0DTC2 | Omicron BA.4/5 SARS-CoV-2 S in complex with TH281 Fab | |
7YVN | 7YVN | Omicron BA.4/5 SARS-CoV-2 S in complex with TH281 Fab | |
7WJZ | 7WJZ | Omicron Spike bitrimer with 6m6 antibody | |
7WJZ | P0DTC2 | Omicron Spike bitrimer with 6m6 antibody | |
7TGW | P0DTC2 | Omicron spike at 3.0 A (open form) | |
7WJY | P0DTC2 | Omicron spike trimer with 6m6 antibody | |
7WJY | 7WJY | Omicron spike trimer with 6m6 antibody | |
8UPX | 8UPX | Omicron-S-MERS-RBD | |
8UPX | A0A0U2MMB6 | Omicron-S-MERS-RBD | |
8UPX | A0A7T8KZF1 | Omicron-S-MERS-RBD | |
8UPX | A0A8B1J577 | Omicron-S-MERS-RBD | |
8UPX | 8UPX | Omicron-S-MERS-RBD | |
8UPX | A0A0U2MMB6 | Omicron-S-MERS-RBD | |
8UPX | A0A7T8KZF1 | Omicron-S-MERS-RBD | |
8UPX | A0A8B1J577 | Omicron-S-MERS-RBD | |
2XE3 | Q9K597 | OmpC28 | |
6ENE | A0A0M7H8A9 | OmpF orthologue from Enterobacter cloacae (OmpE35) | |
8WZI | P0DTC2 | One RBD up state of Spike glycoprotein, SARS-CoV-2 | |
7SBL | P0DTC2 | One RBD-up 1 of pre-fusion SARS-CoV-2 Delta variant spike protein | |
7SBS | P0DTC2 | One RBD-up 1 of pre-fusion SARS-CoV-2 Gamma variant spike protein | |
7SBQ | P0DTC2 | One RBD-up 1 of pre-fusion SARS-CoV-2 Kappa variant spike protein | |
7SBO | P0DTC2 | One RBD-up 2 of pre-fusion SARS-CoV-2 Delta variant spike protein |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.1.0
Last updated: December 9, 2024